| __timestamp | Sarepta Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 94103000 | 9216000000 |
| Thursday, January 1, 2015 | 146194000 | 8296000000 |
| Friday, January 1, 2016 | 130000 | 10044000000 |
| Sunday, January 1, 2017 | 7353000 | 11560000000 |
| Monday, January 1, 2018 | 34193000 | 10558000000 |
| Tuesday, January 1, 2019 | 56586000 | 9351000000 |
| Wednesday, January 1, 2020 | 63382000 | 8933000000 |
| Friday, January 1, 2021 | 97049000 | 8284000000 |
| Saturday, January 1, 2022 | 139989000 | 7952000000 |
| Sunday, January 1, 2023 | 150343000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. This chart compares the cost of revenue for Teva Pharmaceutical Industries Limited and Sarepta Therapeutics, Inc. from 2014 to 2023. Teva, a global leader, consistently reported costs in the billions, peaking at approximately $11.56 billion in 2017. In contrast, Sarepta, a niche player, saw its costs rise from $94 million in 2014 to $150 million in 2023, reflecting a growth of over 60% in the last decade. This stark difference highlights the scale and operational strategies of these companies. While Teva's costs have shown a downward trend, dropping by about 30% from 2017 to 2023, Sarepta's costs have steadily increased, indicating its expanding market presence. This comparison offers a glimpse into the financial dynamics of two distinct pharmaceutical paths.
Cost of Revenue Trends: Johnson & Johnson vs Sarepta Therapeutics, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Sarepta Therapeutics, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Alkermes plc's Expenses
United Therapeutics Corporation vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Evotec SE's Expenses